Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.
Bicchetti M, Simone G, Giannarini G, Girometti R, Briganti A, Brunocilla E, Cardone G, De Cobelli F, Gaudiano C, Del Giudice F, Flammia S, Leonardo C, Pecoraro M, Schiavina R, Catalano C, Panebianco V. Bicchetti M, et al. Among authors: giannarini g. Radiol Med. 2022 Aug;127(8):881-890. doi: 10.1007/s11547-022-01513-5. Epub 2022 Jun 28. Radiol Med. 2022. PMID: 35763251 Free PMC article.
Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 2014;65:1058-66.
Ost P, Briganti A, Giannarini G; Prostate Cancer Working Group of the Young Academic Urologist Working Party of the European Association of Urology. Ost P, et al. Among authors: giannarini g. Eur Urol. 2014 Jun;65(6):e97-8. doi: 10.1016/j.eururo.2013.12.009. Epub 2013 Dec 17. Eur Urol. 2014. PMID: 24365126 No abstract available.
Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients.
Ploussard G, Isbarn H, Briganti A, Sooriakumaran P, Surcel CI, Salomon L, Freschi M, Mirvald C, van der Poel HG, Jenkins A, Ost P, van Oort IM, Yossepowitch O, Giannarini G, van den Bergh RC; Members of the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology. Ploussard G, et al. Among authors: giannarini g. Urol Oncol. 2015 Feb;33(2):71.e1-9. doi: 10.1016/j.urolonc.2014.07.007. Epub 2014 Aug 15. Urol Oncol. 2015. PMID: 25131660
Reply to M. Valerio et al.
Giannarini G, Gandaglia G, Montorsi F, Briganti A. Giannarini G, et al. J Clin Oncol. 2014 Nov 10;32(32):3681-2. doi: 10.1200/JCO.2014.57.7353. Epub 2014 Aug 18. J Clin Oncol. 2014. PMID: 25135993 No abstract available.
Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review.
Surcel CI, van Oort IM, Sooriakumaran P, Briganti A, De Visschere PJ, Fütterer JJ, Ghadjar P, Isbarn H, Ost P, van den Bergh RC, Yossepowitch O, Giannarini G, Ploussard G; Members of the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology. Surcel CI, et al. Among authors: giannarini g. Urol Oncol. 2015 Jun;33(6):265.e1-7. doi: 10.1016/j.urolonc.2014.08.007. Epub 2014 Sep 17. Urol Oncol. 2015. PMID: 25238700 Review.
269 results